@sarvvyapi @ShivaSh15275914 @BaadAbhinav @Profdilipmandal@kiranshaw I was better off without having to read this dumb statement spelled out. Betrays the comprehension and logical skills of the writer.
@rohan_mahadevan @BaadAbhinav @Profdilipmandal@kiranshaw You’ve drank too much theory and applied too little brain to its applicability in use cases. What do you need efficiency for when there is a shortage? Life saving drugs are not for efficient profiteering, from a policy POV. GOI should make multiple producers
@BaadAbhinav @Profdilipmandal@kiranshaw But the innovation didn’t happen at the manufacturer’s expense or initiative even in case of Covaxin. It happened at govt institutions with public money.
@rohan_mahadevan @BaadAbhinav @Profdilipmandal@kiranshaw Oh right. And it couldn’t be produced otherwise if a lot of smaller factory owners had come together to produce the vaccine according to their capacities and provided cumulatively the government with required numbers.
@BaadAbhinav @aniruddha_sigh @Profdilipmandal@kiranshaw Oh you think service providers are more and there is a healthy competition in the Indian market? Very cute. They’re literally monopolies each copying & producing a specific kind of vaccine. Concentrating wealth against right to immunity.
@BaadAbhinav @Profdilipmandal@kiranshaw Indian elites are making money on vaccine production and selling. They didn’t invent it, only copied foreign IP with Indian govt’s big help.
Here comes our latest #Blog on "Knowledge Repo for #DataScience " by our Data Science Intern @navinchandan. Click here to read: https://t.co/CbpLUbzimW